The independent source for health policy research, polling, and news.
101-120 of 112,972 results
MPR News reported that Dr. Ishan Patel and his wife, Dr. Akanksha Patel, were on a pilgrimage after he graduated from a fellowship with the University of Minnesota’s Department of Orthopedic Surgery. Also: striking doctors in Minnesota, hospital executives' pay, fake doctor reviews, and more.
The researcher, Jacob Coxon, quit his job Tuesday at Anthropic and accused the company — as well as its chief rival, OpenAI, where he previously worked — of acting irresponsibly with human life. Artificial intelligence "could kill us all by the end of the decade," he warned in a social media post.
The report from the HHS Office of Inspector General found that some organs were used in transplants that were not covered by Medicare and still others were not transplanted at all, MedPage Today reported. Also: Medicare Advantage plans may be headed for benefit cuts in 2027, Axios reported.
The organizational change, planned under the Biden administration, will combine the agency's flu and covid divisions to streamline respiratory viral disease surveillance and support to state and local entities. Plus, the latest election news, including President Donald Trump's pledge to send $500 rebate checks to some people enrolled in Obamacare.
Today's early morning highlights from the major news organizations.
Editorial writers discuss these public health topics.
Camizestrant's approval as a first-line treatment goes against recommendations from the agency's outside experts. Also in the news, new immunotherapy results for some cancers; AI-generated drugs for lung disease; and more.
In 2017, the suicide rate of 10- to 14-year-old boys was twice that of girls, but by 2024, it was only 4% higher, new research has found, marking the "first time this has happened in the available records," MedPage Today reported. Also: a look at the impact that early treatment has on psychosis recovery.
A ProPublica analysis of data from the Centers for Disease Control and Prevention found that nearly 200 women with the condition died from 2020 to 2025, compared with about 100 in the six years before. Also in the news: A federal appeals court in Louisiana will hear arguments Wednesday over mail-order mifepristone.
On Tuesday, the city released about 170,000 pages of documents related to air quality after the destruction of the World Trade Center in Lower Manhattan. Mayor Zohran Mamdani declined to give the names of leaders he believed had lied. At the time of the attacks, Rudy Giuliani was mayor and Christine Todd Whitman was EPA administrator; both assured residents the air was safe to breathe, The New York Times said.
A Catholic mother in New York had argued that her faith forbids her to accept vaccines for herself or her son. “Vaccination injects biological material derived from unclean sources directly into the bloodstream. My faith forbids this,” she wrote in a statement. The court effectively sided with state and local officials' public health push to protect the general population from disease.
Three have been serving as acting directors: Michael Davis at the Center for Drug Evaluation and Research; Karim Mikhail at the Center for Biologics Evaluation and Research; and Bret Koplow at the Center for Tobacco Products. Jared Seehafer will oversee technology and artificial intelligence in a newly created position.
Today's early morning highlights from the major news organizations.
Opinion writers tackle these public health topics.
The research, published in JAMA Network Open, indicates that from 2005 to 2023, the rate of women who had never received a cervical cancer screening when they were ages 21 to 29 increased from 12.5% to 31.9%, CIDRAP reported. Also: HPV vaccine rates among teens, high-fructose corn syrup's impact on the gut, and more.
The algorithm, called InterRAI, has already cut funding to almost 900 Nebraskans and is being rolled out in Ohio and Indiana. Other states making news: California, Minnesota, Colorado, Georgia, Massachusetts, and more.
According to data from an employer survey from the Business Group on Health, only 60% of large employers are covering GLP-1 drugs, a decrease from 72% in 2025, Modern Healthcare reported, noting that employers are wrestling with the long-term health benefits of GLP-1s alongside their significant cost.
Stanford researchers found that in 2024, more than two-thirds of new drugs approved by the FDA were sanctioned based on findings from a single study, CIDRAP reported. The findings also show a sharp increase in industry-sponsored studies. The senior author of the analysis called the results "concerning, as it allows products to reach the market without independent confirmation of the findings.”
The cyclosporiasis outbreak has laid bare the shortcomings at the Food and Drug Administration, which lost inspectors during the covid pandemic and never recovered. Food experts say inspectors should have been on-site in Mexico at the farm tied to tainted lettuce sooner, considering the scale and number of people sickened, the AP reported.
© 2026 KFF